Document:

exv10w8

 

EXHIBIT 10.8

AMENDED AND RESTATED

EMPLOYMENT AGREEMENT

     AMENDED AND RESTATED EMPLOYMENT AGREEMENT made and entered into by and between United Surgical
Partners International, Inc. (the “Company”), a Delaware corporation with its principal place of
business at 15305 Dallas Parkway, Suite 1600, Addison, TX 75001-6491 and John J. Wellik of 4418
Goodfellow Dr., Dallas, TX 75229 (the “Executive”), effective as of the 19th day of April, 2007
(the “Effective Date”).

     WHEREAS, the Company and Executive are parties to an Employment Agreement effective as of July
1, 2005 (the “Original Agreement”); and

     WHEREAS, the Company and Executive desire to amend and restate the Original Agreement in its
entirety as provided herein.

     In consideration of the mutual promises, terms, provisions and conditions set forth in this
Agreement, the parties hereby agree:

     1. Employment. Subject to the terms and conditions set forth in this Agreement, the
Company hereby offers and the Executive hereby accepts employment.

     2. Term. The Company hereby agrees to employ Executive as Senior Vice President,
Accounting and Administration, and Executive hereby agrees to accept such employment, on the terms
and conditions set forth herein, for the period commencing on the date hereof (the “Effective
Date”) and terminating as of and on the first anniversary of the Effective Date (unless sooner
terminated as hereinafter set forth) (the “Term”); provided, however, that
commencing on such first anniversary date, and each anniversary of the date hereof thereafter, the
Term of this Agreement shall automatically be extended for one additional year unless at least
thirty (30) calendar days prior to each such anniversary date, the Company or Executive shall have
given notice that it or he, as applicable, does not wish to extend this Agreement. Following the
date on which the Executive’s employment so terminates (the “Termination Date”), unless
specifically otherwise agreed between Executive and the Company, the Executive shall cease to hold
any position (whether as an officer, director, manager, employee, trustee, fiduciary or otherwise)
with the Company or any of its Subsidiaries or Affiliates.

     3. Capacity and Performance.

     (a) During the term of Executive’s employment hereunder, the Executive shall serve the
Company as its Senior Vice President, Accounting and Administration. In addition, and
without further compensation, the Executive shall serve as a director and/or officer of one
or more of the Company’s Subsidiaries if so elected or appointed from time to time.

     (b) During the term of Executive’s employment hereunder, the Executive shall be
employed by the Company on a full-time basis and shall perform such duties and
responsibilities on behalf of the Company and its Subsidiaries as may be designated from

 

 

time to time by the Chief Executive Officer and/or by the Executive’s immediate
supervisor.

     (c) During the term of Executive’s employment hereunder, the Executive shall devote his
full business time to the advancement of the business and interests of the Company and its
Subsidiaries and to the discharge of his duties and responsibilities hereunder. The
Executive shall not engage in any other business activity or serve in any industry, trade,
professional, governmental or academic position during the term of this Agreement, except as
may be expressly approved in advance by the Chief Executive Officer in writing.
Notwithstanding the preceding, the Executive may, without being in violation of the
Executive’s obligations hereunder, (i) serve on corporate, civic or charitable boards, or
committees which are not engaged in business competition with the Company, and (ii) invest
the Executive’s personal assets in such form or manner as will not require any material
services by the Executive in the operation of the entities in which such investments are
made, provided the Executive shall use the Executive’s best efforts to pursue such
activities in such a manner so that such activities shall not prevent the Executive from
fulfilling the Executive’s obligations to the Company hereunder.

     4. Compensation and Benefits. During the term of Executive’s employment hereunder as
compensation for all services performed by the Executive:

     (a) Base Salary. The Company shall pay the Executive a base salary at the rate
of Two Hundred Forty-Seven Thousand Dollars ($247,000) per year, payable in accordance with
the payroll practices of the Company for its executives and subject to increase from time to
time by the Chief Executive Officer, in his sole discretion. Such base salary, as from time
to time increased, is hereafter referred to as the “Base Salary”.

     (b) Bonus. During the Term of this Agreement, the Company may pay to the
Executive such bonus payments, if any, as may be determined by the Board in its sole
discretion, based upon the Executive’s performance and other criteria as may be established
by the Board from time to time.

     (c) Vacations. The Executive shall be entitled to vacation days as determined
in accordance with the Company’s vacation policy as in effect from time to time. For
purposes of this Section 4(c), weekends shall not count as vacation days and Executive shall
also be entitled to all paid holidays given by the Company to its senior executive officers.
Vacation shall otherwise be governed by the policies of the Company, as in effect from time
to time.

     (d) Other Benefits. Subject to any contribution therefor generally required of
executives of the Company, the Executive shall be entitled to participate in any and all
employee benefit plans from time to time in effect for executives of the Company generally,
except to the extent such plans are in a category of benefit specifically otherwise provided
to the Executive under this Agreement (e.g., severance pay). Such participation shall be
subject to the terms of the applicable plan documents and generally applicable Company
policies. The Board of Directors of the Company (the “Board”)

-2-

 

may alter, modify, add to or delete employee benefit plans at any time as it, in its
sole judgment, determines to be appropriate.

     (e) Business Expenses. The Company shall pay or reimburse the Executive for
all reasonable and necessary business expenses incurred or paid by the Executive in the
performance of his duties and responsibilities hereunder, subject to any maximum annual
limit or other restrictions on such expenses set by the Board and to such reasonable
substantiation and documentation as may be specified by the Company from time to time.

     5. Termination of Employment. The Executive’s employment hereunder shall terminate
under the following circumstances:

     (a) Death. In the event of the Executive’s death during the term of
Executive’s employment hereunder, the Executive’s employment shall immediately and
automatically terminate.

     (b) Disability. The Company may terminate the Executive’s employment
hereunder, upon notice to the Executive, in the event that the Executive becomes disabled
during his employment hereunder through any illness, injury, accident or condition of either
a physical or psychological nature and, as a result, is unable to satisfactorily perform his
duties and responsibilities hereunder on a full-time basis, with or without reasonable
accommodation, for ninety (90) days during any period of three hundred and sixty-five (365)
consecutive calendar days. If any question shall arise as to whether during any period the
Executive is disabled through any illness, injury, accident or condition of either a
physical or psychological nature so as to be unable to perform substantially all of his
duties and responsibilities hereunder, the Executive, at the request of the Company, shall
submit to a medical examination by a physician selected by the Company to determine whether
the Executive is so disabled and such determination shall for the purposes of this Agreement
be conclusive of the issue. If such question shall arise and the Executive shall fail to
submit to such medical examination, the Company’s determination of the issue shall be
binding on the Executive.

     (c) By the Company for Cause. The Company may terminate the Executive’s
employment hereunder for Cause at any time upon notice to the Executive setting forth the
nature of such Cause. The following shall constitute Cause for termination (in each case as
determined by not less than seventy-five percent (75%) of the members of the Board): (i) the
Executive’s indictment for a felony or other crime involving moral turpitude; (ii) the
Executive’s fraud, theft or embezzlement committed with respect to the Company or its
Subsidiaries; (iii) material breach by the Executive of any of the provisions of Sections 7,
8 and/or 9 hereof; or (iv) the Executive’s willful and continued failure to perform his
material duties to the Company and its Subsidiaries.

     (d) By the Company Other than for Cause. The Company may terminate the
Executive’s employment hereunder other than for Cause at any time upon notice to the
Executive.

-3-

 

     (e) By the Executive for Good Reason. At his option, Executive may terminate
his employment hereunder for Good Reason. For purposes of this Agreement, the termination
of Executive’s employment hereunder by Executive because of the occurrence of any one or
more of the following events shall be deemed to have occurred for “Good Reason”;

	 	(A)	 	a material change in the nature or scope of
Executive’s authorities, status, powers, functions, duties,
responsibilities, or reporting relationships that is determined by
Executive in good faith to be adverse to those existing before such
change;
	 
	 	(B)	 	a material reduction in Executive’s Base Salary
that is not consented to or approved by Executive;
	 
	 	(C)	 	a failure by the Company or any subsidiary or
affiliate of the Company to comply with any other material term or
provision hereof or of any other written agreement between Executive
and the Company or any such subsidiary or affiliate; or
	 
	 	(D)	 	a refusal by the Executive upon a request by
the Company to report for the performance of his services hereunder on
a regular or permanent basis at any location or office more than fifty
(50) miles from the Company’s current address as described above in the
preamble to this Agreement or Executive’s current place of employment.

     (f) By the Executive Other than for Good Reason. The Executive may terminate
his employment hereunder other than for Good Reason pursuant to Section 5(e) above at any
time upon the provision of 90 days written notice to the Company. In the event of
termination of the Executive pursuant to this Section 5(f), the Board may elect to waive the
period of notice or any portion thereof.

     6. Compensation Upon Termination.

     (a) Death. In the event of a termination of the Executive’s employment
hereunder by reason of death as contemplated by Section 5(a), the Company shall pay in a
lump sum within 30 days of such termination to the Executive’s designated beneficiary or, if
no beneficiary has been designated by the Executive, to his estate, the Base Salary earned
but not paid through the Termination Date.

     (b) Disability. In the event of any termination of Executive’s employment
hereunder by reason of disability as contemplated by Section 5(b), the Company shall pay to
him his Base Salary earned but not paid through the Termination Date.

     (c) By the Company for Cause. In the event of any termination of Executive’s
employment hereunder by the Company for Cause as contemplated by Section 5(c), the Company
shall have no further obligations to the Executive under this Agreement other than payment
of Base Salary through the Termination Date.

-4-

 

     (d) By the Company Other than for Cause or Upon Failure to Renew; By the Executive
for Good Reason. In the event of any termination of Executive’s employment hereunder by
the Company other than for Cause pursuant to Section 5(d) or pursuant to Section 2 following
notice that the Company does not wish to extend this Agreement for an additional one year
period, or by the Executive for Good Reason pursuant to Section 5(e), the Company shall (i)
continue to pay the Executive the Base Salary at the rate in effect on the Termination Date
for twelve (12) months, (ii) continue the Executive’s health insurance benefits for twelve
(12) months following the Termination Date (at a cost no less favorable than that paid by
the Executive immediately prior to the Termination Date) or the economic equivalent thereof
if such continuation is not permissible under the terms of the Company’s health insurance
plan, and (iii) pay to the Executive a good faith estimate of the bonus the Executive would
have received had the Executive remained employed by the Company through the end of the
fiscal year in which the Termination Date occurred, as determined by the Company in its sole
and absolute discretion. Any such estimated bonus shall be payable at such time or times as
bonuses are payable to the other executives of the Company. Any obligation of the Company
to the Executive pursuant to this Section 6(d) conditioned upon (i) the Executive signing a
release of claims in the form appended hereto as Attachment A (the “Employee
Release”) within twenty-one (21) days (or such greater period as the Company may specify)
following the date notice of termination of employment is given hereunder and upon the
Executive’s not revoking the Employee Release in a timely manner thereafter and (ii) the
Executive’s continued full performance of his continuing obligations hereunder, including
those under Sections 7, 8 and/or 9 hereof. Base Salary to which the Executive is entitled
under this Section 6(d) shall be payable in accordance with the normal payroll practices of
the Company and will begin at the Company’s next regular payroll period which is at least
five business days following the effective date of the Employee Release, but shall be
retroactive to next business day following the Termination Date.

     (e) By the Executive Other than for Good Reason. If the Executive shall
terminate his employment pursuant to Section 5(f), the Company shall continue to pay
Executive his Base Salary through the Termination Date (it being understood that if, in
accordance with Section 5(f), the Board elects to waive the period of notice, or any portion
thereof, the payment of Base Salary under this Section 6(e) shall continue through the
notice period or any portion thereof so waived).

     7. Restricted Activities. The Executive agrees that some restrictions on his
activities during and after his employment are necessary to protect the goodwill, Confidential
Information and other legitimate interests of the Company and its Subsidiaries:

     (a) While the Executive is employed by the Company and for one (1) year from the later
of the Termination Date or the last date on which the Executive receives a severance payment
from the Company (in the aggregate, the “Non-Competition Period”), the Executive shall not,
directly or indirectly, whether as owner, partner, investor, consultant, agent, employee,
co-venturer or otherwise (other than through ownership of publicly-traded capital stock of
a corporation which represents less than one (1%) of the outstanding capital stock of such
corporation), (i) compete with the Company or any

-5-

 

Subsidiary in any business activities, in the United States or in any other country,
which the Company or any Subsidiary shall conduct or intend to conduct as of the Termination
Date, or (ii) undertake any planning for any business competitive with the Company or any of
its Subsidiaries. Specifically, but without limiting the foregoing, the Executive agrees
not to engage in any manner in any activity that is directly or indirectly competitive or
potentially competitive with the business of the Company or any of its Subsidiaries as
conducted or under consideration at any time during the Executive’s employment with the
Company or any of its Subsidiaries (including prior to the date hereof).

     (b) The Executive agrees that, during his employment with the Company, he will not
undertake any outside activity, whether or not competitive with the business of the Company
or its Subsidiaries, that could reasonably give rise to a conflict of interest or otherwise
interfere with his duties and obligations to the Company or any of its Subsidiaries.

     (c) The Executive further agrees that while he is employed by the Company and during
the Non-Competition Period, the Executive will not, directly or indirectly, (i) hire or
attempt to hire any employee of the Company or any of its Subsidiaries or anyone who was
such an employee within the six (6) months preceding such hire or attempt to hire, (ii) hire
or attempt to hire any independent contractor providing services to the Company or any of
its Subsidiaries or anyone who was such an independent contractor within six (6) months
preceding such hire or attempt to hire, (iii) assist in hiring or any attempt to hire of
anyone identified in clauses (i) or (ii) of this sentence by any other Person, (iv)
encourage any employee or independent contractor of the Company or any of its Subsidiaries
to terminate his relationship with the Company or any of its Subsidiaries, or (v) solicit or
encourage any customer or vendor of the Company or any of its Subsidiaries (including
physicians holding clinical privileges at any surgical facility in which the Company has a
direct or indirect ownership interest or with which a subsidiary of the Company has a
management agreement) to terminate or diminish its relationship with any of them, or, in the
case of a customer, to conduct with any Person any business or activity which such customer
conducts or could conduct with the Company or any of its Subsidiaries.

     8. Confidential Information.

     (a) The Executive acknowledges that the Company and its Subsidiaries continually
develop Confidential Information, that the Executive has in the past and may in the future
develop Confidential Information for the Company or its Subsidiaries and that the Executive
has in the past and may in the future learn of Confidential Information during the course of
employment. The Executive will comply with the policies and procedures of the Company and
its Subsidiaries for protecting Confidential Information and shall never use or disclose to
any Person (except as required by applicable law or for the proper performance of his duties
and responsibilities to the Company and its Subsidiaries), any Confidential Information
obtained by the Executive incident to his employment or other association with the Company
or any of its Subsidiaries. The

-6-

 

Executive understands that this restriction shall continue to apply after his
employment terminates, regardless of the reason for such termination.

     (b) All documents, records, tapes and other media of every kind and description
relating to the business, present or otherwise, of the Company or its Subsidiaries and any
copies, in whole or in part, thereof (the “Documents”), whether or not prepared by the
Executive, shall be the sole and exclusive property of the Company and its Subsidiaries.
The Executive shall safeguard all Documents and shall surrender to the Company at the time
his employment terminates, or at such earlier time or times as the Board or its designee may
specify, all Documents then in the Executive’s possession or control.

     9. Assignment of Rights to Intellectual Property. The Executive shall promptly and
fully disclose all Intellectual Property to the Company. The Executive hereby assigns and agrees
to assign to the Company (or as otherwise directed by the Company) the Executive’s full right,
title and interest in and to all Intellectual Property. The Executive agrees to execute any and
all applications for domestic and foreign patents, copyrights or other proprietary rights and to do
such other acts (including without limitation the execution and delivery of instruments of further
assurance or confirmation) requested by the Company to assign the Intellectual Property to the
Company and to permit the Company to enforce any patents, copyrights or other proprietary rights to
the Intellectual Property. The Executive will not charge the Company for time spent in complying
with these obligations. All copyrightable works that the Executive creates shall be considered
“work made for hire”.

     10. Notification Requirement. Until the conclusion of the Non-Competition Period, the
Executive shall give notice to the Company of each new business activity that he plans to undertake
at least thirty (30) days prior to beginning any such activity. Such notice shall state the name
and address of the Person for whom such activity is undertaken and the nature of the Executive’s
business relationship(s) and position(s) with such Person. The Executive shall provide the Company
with such other pertinent information concerning such business activity as the Company may
reasonably request in order to determine the Executive’s continued compliance with his obligations
under Sections 7, 8 and/or 9 hereof.

     11. Enforcement of Covenants. The Executive acknowledges that he has carefully read
and considered all the terms and conditions of this Agreement, including the restraints imposed
upon him pursuant to Sections 7, 8 and/or 9 hereof. The Executive agrees that said restraints are
necessary for the reasonable and proper protection of the Company and its Subsidiaries and that
each and every one of the restraints is reasonable in respect to subject matter, length of time and
geographic area. The Executive further acknowledges that, were he to breach any of the covenants
contained in Sections 7, 8 and/or 9 hereof, the damage to the Company would be irreparable. The
Executive therefore agrees that the Company, in addition to any other remedies available to it,
shall be entitled to preliminary and permanent injunctive relief against any breach or threatened
breach by the Executive of any of said covenants, without having to post bond. The parties further
agree that, in the event that any provision of Sections 7, 8 and/or 9 hereof shall be determined by
any court of competent jurisdiction to be unenforceable by reason of its being extended over too
great a time, too large a geographic area or too great a

-7-

 

range of activities, such provision shall be deemed to be modified to permit its enforcement
to the maximum extent permitted by law.

     12. Conflicting Agreements. The Executive hereby represents and warrants that the
execution of this Agreement and the performance of his obligations hereunder will not breach or be
in conflict with any other agreement to which the Executive is a party or is bound and that the
Executive is not now subject to any covenants against competition or similar covenants or any court
order or other legal obligation that would affect the performance of his obligations hereunder.
The Executive will not disclose to or use on behalf of the Company any proprietary information of a
third party without such party’s consent.

     13. Definitions. Words or phrases which are initially capitalized or are within
quotation marks shall have the meanings provided in this Section 13 and as provided elsewhere
herein. For purposes of this Agreement, the following definitions apply:

     (a) “Affiliate” means, with respect to the Company or any other specified Person, any
other Person directly or indirectly controlling, controlled by or under common control with
the Company or such other specified Person, where control may be by management authority,
equity interest or other means.

     (b) “Confidential Information” means any and all information of the Company and its
Subsidiaries that is not generally known by others with whom they compete or do business, or
with whom they plan to compete or do business and any and all information which, if
disclosed by the Company or its Subsidiaries, would assist in competition against them.
Confidential Information includes without limitation such information relating to (i) the
development, research, testing, manufacturing, marketing and financial activities of the
Company and its Subsidiaries, (ii) the Products, (iii) the costs, sources of supply,
financial performance and strategic plans of the Company and its Subsidiaries, (iv) the
identity and special needs of the customers of the Company and its Subsidiaries and (v) the
people and organizations with whom the Company and its Subsidiaries have business
relationships and those relationships. Confidential Information also includes any
information that the Company or any of its Subsidiaries have received, or may receive
hereafter, from others which was received by the Company or any of its Subsidiaries with any
understanding, express or implied, that the information would not be disclosed.

     (c) “Intellectual Property” means inventions, discoveries, developments, methods,
processes, compositions, works, concepts and ideas (whether or not patentable or
copyrightable or constituting trade secrets) conceived, made, created, developed or reduced
to practice by the Executive (whether alone or with others and whether or not during normal
business hours or on or off the premises of the Company or any of its Subsidiaries) during
the Executive’s employment with the Company or any of its Subsidiaries (including prior to
the Effective Date) that relate to either the Products or any prospective activity of the
Company or any of its Subsidiaries or that make use of Confidential Information or any of
the equipment or facilities of the Company or any of its Subsidiaries.

-8-

 

     (d) “Person” means an individual, a corporation, a limited liability company, an
association, a partnership, an estate, a trust and any other entity or organization.

     (e) “Products” mean all products planned, researched, developed, tested, manufactured,
sold, licensed, leased or otherwise distributed or put into use by the Company or any of its
Subsidiaries, together with all services provided or planned by the Company or any of its
Subsidiaries, during the Executive’s employment with the Company or any of its Subsidiaries
(including prior to the Effective Date).

     (f) “Subsidiary” shall mean any Person of which the Company (or other specified Person)
shall, directly or indirectly, own beneficially or control the voting of at least a majority
of the outstanding capital stock (or other shares of beneficial interest) entitled to vote
generally or at least a majority of the partnership, membership, joint venture or similar
interests, or in which the Company (or other specified Person) or a Subsidiary thereof shall
be a general partner or joint venturer without limited liability.

     14. Survival. The provisions of this Agreement shall survive following the
Termination Date if so provided herein or desirable to accomplish the purposes of other surviving
provisions, including without limitation the provisions of Section 6, 7, 8 and 9 hereof.

     15. Withholding. All payments made by the Company under this Agreement shall be
reduced by any tax or other amounts required to be withheld by the Company under applicable law.

     16. Assignment. Neither the Company nor the Executive may make any assignment of this
Agreement or any interest herein, by operation of law or otherwise, without the prior written
consent of the other; provided, however, that the Company may assign its rights and obligations
under this Agreement without the consent of the Executive in the event that the Company shall
hereafter effect a reorganization, consolidation or merger or to whom the Company transfers all or
substantially all of its properties or assets. This Agreement shall inure to the benefit of and be
binding upon the Company and the Executive, their respective successors, executors, administrators,
heirs and permitted assigns.

     17. Severability. If any portion or provision of this Agreement shall to any extent
be declared illegal or unenforceable by a court of competent jurisdiction, then the remainder of
this Agreement, or the application of such portion or provision in circumstances other than those
as to which it is so declared illegal or unenforceable, shall not be affected thereby, and each
portion and provision of this Agreement shall be valid and enforceable to the fullest extent
permitted by law.

     18. Waiver. No waiver of any provision hereof shall be effective unless made in
writing and signed by the waiving party. The failure of either party to require the performance of
any term or obligation of this Agreement, or the waiver by either party of any breach of this
Agreement, shall not prevent any subsequent enforcement of such term or obligation or be deemed a
waiver of any subsequent breach.

     19. Notices. Any and all notices, requests, demands and other communications provided
for by this Agreement shall be in writing and shall be effective when delivered in

-9-

 

person, when delivered by courier at the Executive’s last known address on the books of the
Company, or three business days following deposit in the United States mail, postage prepaid,
registered or certified, and addressed to the Executive at his last known address on the books of
the Company or, in the case of the Company, at its principal place of business, attention of the
Chairman of the Board, or to such other address as either party may specify by notice to the other
actually received.

     20. Original Agreement. This Agreement shall amend and restate the Original Agreement
in its entirety and upon execution and delivery of this Agreement, the Original Agreement shall be
replaced in its entirety by this Agreement and the Original Agreement shall thereafter have no
further force or effect.

     21. Entire Agreement. This Agreement and the other plans and documents specifically
referred to herein constitute the entire agreement between the parties regarding the subject matter
of this Agreement and such other plans and documents and supersede all prior communications,
agreements and understandings, written or oral, with respect to such subject matter, including,
without limitation, the Original Agreement.

     22. Amendment. This Agreement may be amended or modified only by a written instrument
signed by the Executive and by a expressly authorized representative of the Company.

     23. Headings. The headings and captions in this Agreement are for convenience only
and in no way define or describe the scope or content of any provision of this Agreement.

     24. Counterparts. This Agreement may be executed in two or more counterparts, each of
which shall be an original and all of which together shall constitute one and the same instrument.

     25. Governing Law. This contract and shall be construed and enforced under and be
governed in all respects by the laws of Texas, without regard to the conflict of laws principles
thereof.

-10-

 

     IN WITNESS WHEREOF, this Agreement has been executed as a sealed instrument by the Company, by
its duly authorized representative, and by the Executive, as of the date first above written.

	 	 	 	 	 	 	 
	 	 	UNITED SURGICAL
PARTNERS
INTERNATIONAL, INC.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ William H. Wilcox	 	 
	 

	 	 	 	 	 	 
	 

	 	 	 	Title: President	 	 
	 
	 	 	 	 	 	 
	 	 	THE EXECUTIVE:	 	 
	 
	 	 	 	 	 	 
	 	 	/s/ John J. Wellik	 	 
	 	 	 	 	 

SIGNATURE PAGE TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT

 

 

Attachment A

Release of Claims

     FOR AND IN CONSIDERATION OF the special payments and benefits to be provided in connection
with the termination of my employment in accordance with the terms of the Employment Agreement
between me and UNITED SURGICAL PARTNERS INTERNATIONAL, INC. a Delaware corporation (the “Company”)
dated as of April 19, 2007 (the “Employment Agreement”), I, on my own behalf and on behalf of my
personal or legal representatives, executors, administrators, successors, heirs, distributees,
devisees and legatees and all others connected with me, hereby release and forever discharge, the
Company, its Subsidiaries and Affiliates and all of their respective past and present officers,
directors, stockholders, members, partners, managers, controlling persons, employees, agents,
representatives, successors and assigns and all others connected with any of them (all
collectively, the “Released”), both individually and in their official capacities, from any and all
rights, liabilities, claims, demands and causes of action of any type (all collectively “Claims”)
which I have had in the past, now have, or might now have, through the date of my signing of this
Release of Claims, in any way resulting from, arising out of or connected with my employment or its
termination or pursuant to any federal, state, foreign or local employment law, regulation or other
requirement (including without limitation Title VII of the Civil Rights Act of 1964, the Age
Discrimination in Employment Act, the Americans with Disabilities Act, and the fair employment
practices laws of the state or states in which I have been employed pursuant to the Employment
Agreement, each as amended from time to time); provided, however, that the foregoing release shall
not apply to any right or benefit that Section 6 of the Employment Agreement explicitly provides
shall survive the termination of my employment. Capitalized terms used in this Release of Claims
which are defined in the Employment Agreement are used herein with the meanings so defined.

     In signing this Release of Claims, I acknowledge that I have had at least twenty-one (21) days
from the date of notice of termination of my employment to consider the terms of this Release of
Claims and that such time has been sufficient; that I am encouraged by the Company to seek the
advice of an attorney prior to signing this Release of Claims; and that I am signing this Release
of Claims voluntarily and with a full understanding of its terms.

     I understand that I may revoke this Release of Claims at any time within seven (7) days of the
date of my signing by written notice to the Company and that this Release of Claims will take
effect only upon the expiration of such seven-day revocation period and only if I have not timely
revoked it.

     Intending to be legally bound, I have signed this Release of Claims under seal as of the date
written below.

	 	 	 	 	 
	Signature:
	 	 	 	 
	 

	 	 	 	 
	 

	 	John J. Wellik	 	 
	 
	 	 	 	 
	Date:exv10w9w1

 

Exhibit 10.9.1

FIRST AMENDMENT TO THE

UNITED SURGICAL PARTNERS INTERNATIONAL, INC.

DEFERRED COMPENSATION PLAN

EFFECTIVE JANUARY 1, 2005

     THIS FIRST AMENDMENT (this “First Amendment”) is effective, except as otherwise
specified below, as of the date the transactions contemplated in that certain Agreement and Plan of
Merger among UNCN Holdings, Inc., UNCN Acquisition Corp. and United Surgical Partners
International, Inc., dated as of January 7, 2007 (the “Merger Agreement”), are consummated
(the “Closing Date”), and is made by United Surgical Partners International, Inc., a
Delaware corporation (the “Corporation”) as of April 18, 2007.

W I T N E S S E T H:

     WHEREAS, the Corporation sponsors the United Surgical Partners International, Inc. Deferred
Compensation Plan Effective January 1, 2005 (the “Plan”) for the benefit of its eligible
employees and their beneficiaries;

     WHEREAS, pursuant to Section 13.2 of the Plan, the Corporation may amend the Plan, except that
no such amendment shall decrease a participant’s account balance at the time of such amendment nor
shall any amendment affect the right of any participant or beneficiary who retired (or was eligible
to retire) on or before the effective date of such amendment to receive benefits in the manner he
or she elected;

     WHEREAS, Section 8.1 of the Plan provides that, upon a Change in Control (as such term is
defined in Section 1.9 of the Plan) of the Corporation, each participant shall become fully vested
in his or her account balance in the Plan;

     WHEREAS, the Corporation desires to exclude from the definition of Change in Control in
Section 1.9 of the Plan the transactions contemplated by the Merger Agreement;

     WHEREAS, the Corporation further desires to amend the Plan to eliminate the “deferred stock
benefit” feature, which allows certain Plan participants to defer a portion of their annual bonus
to be invested in the Corporation’s stock;

     WHEREAS, to the extent any participant in the Plan has elected to defer all or any portion of
his or her annual bonus for 2007 in the “deferred stock benefit” feature (the “Deferred Stock
Bonus”), the Corporation desires to amend the Plan to permit such participant to (1) make an
election, pursuant to the transition relief provided pursuant to section 409A of the Internal
Revenue Code of 1986, as amended (the “Code”), to receive in March 2008 a cash payment
equal to all or any portion of such Deferred Stock Bonus, or (2) continue to defer all or any
portion of such Deferred Stock Bonus and have such amounts deemed invested, on a pro rata basis, in
accordance with the participant’s other investment elections under the Plan; and

     WHEREAS, the proposed amendments comply with Section 13.2 of the Plan.

1

 

     NOW, THEREFORE, the Plan is hereby amended, effective as of the Closing Date (except as
otherwise specified below), as follows:

     1. Section 1.9 of the Plan is hereby amended in its entirety, effective January 1, 2007, to
read as follows:

     1.9 “Change in Control” shall mean a change in ownership or control of
the Company effected through any of the following transactions: (a) a merger,
consolidation or other reorganization approved by the Company’s stockholders, UNLESS
securities representing more than fifty percent (50%) of the total combined voting
power of the voting securities of the successor corporation are immediately
thereafter beneficially owned, directly or indirectly and in substantially the same
proportion, by (i) the persons who beneficially owned the Company’s outstanding
voting securities immediately prior to such transaction, or (ii) WCAS; (b) the sale,
transfer or other disposition of all or substantially all of the Company’s assets in
a complete liquidation or dissolution of the Company other than to WCAS; or (c) the
acquisition, directly or indirectly by any person or related group of persons, other
than (i) the Company, (ii) a person that directly or indirectly controls, is
controlled by, or is under common control with, the Company, or (iii) WCAS, of
beneficial ownership (within the meaning of Rule 13d-3 of the Securities Exchange
Act of 1934, as amended from time to time) of securities possessing more than fifty
percent (50%) of the total combined voting power of the Company’s outstanding
securities pursuant to a tender or exchange offer made directly to the Company’s
stockholders; provided, however, that in no event will any of the transactions
contemplated by that certain Agreement and Plan of Merger among UNCN Holdings, Inc.,
UNCN Acquisition Corp. and United Surgical Partners International, Inc., dated as of
January 7, 2007, constitute a Change in Control for purposes of the Plan. In the
event this definition of “Change in Control” fails to meet the limitations or
requirements of section 409A of the Code and the regulations promulgated thereunder,
then this Section 1.9 shall be modified by action of the Committee to the extent
necessary to satisfy the requirements of section 409A of the Code and the
regulations promulgated thereunder.

     2. A new Section 1.10A is hereby added to the Plan to read as follows:

     1.10A “Closing Date” shall mean the date the transactions contemplated
in that certain Agreement and Plan of Merger among UNCN Holdings, Inc., UNCN
Acquisition Corp. and United Surgical Partners International, Inc., dated as of
January 7, 2007, are consummated.

     3. Section 1.18 (“Deferred Stock Benefit”), Section 1.19 (“Deferred Stock Bonus”), and Section
1.20 (“Deferred Stock Participant”) are hereby deleted in their entirety.

     4. Section 1.25 of the Plan is hereby amended in its entirety to read as follows:

2

 

     1.25 “Elective Deferral Account” shall mean the sum of (a) a
Participant’s Deferral Amount, plus (b) earnings, gains, losses, and changes in
value of the Deemed Investments thereon credited (or debited) in accordance with
Section 3.7, net of all distributions from such account. This Account shall be a
bookkeeping entry only and shall be utilized solely as a device for the measurement
and determination of the amounts to be paid to the Participant pursuant to the Plan.
The Elective Deferral Account shall also include (x) the participant accounts
previously held under the United Surgical Partners International, Inc. Deferred
Compensation Plan, effective February 12, 2002, which were originally deemed
invested in Stock but which are now deemed invested pursuant to Section 3.6, and (y)
the participant accounts previously held under the United Surgical Partners
International, Inc. Supplemental Retirement Plan.

     5. Section 1.28 (“Fair Market Value”) of the Plan is hereby deleted in its entirety.

     6. A new Section 1.42A is hereby added to the Plan to read as follows:

     1.42A “WCAS” shall mean Welsh, Carson, Anderson & Stowe X, L.P., a
Delaware limited partnership, and any entity controlled by it.

     7. Section 2.1 of the Plan is hereby amended in its entirety to read as follows:

     2.1 Selection by Committee. Participation in the Plan shall be limited
to (a) non-employee directors of an Employer and (b) employees of an Employer who
are part of a select group of management or highly compensated employees. From the
foregoing, the Committee shall select, in its sole and absolute discretion,
individuals to participate in the Plan.

     8. Section 3.1 of the Plan is hereby amended in its entirety to read as follows:

     3.1 Deferred Compensation.

          (a) Minimum. For each Plan Year, a Participant may elect to defer Base
Salary and/or Annual Bonus otherwise payable in respect of such Plan Year in the
following minimum amounts for each deferral elected:

	 	 	 	 	 
	Deferral	 	Minimum Amount
	Base Annual Salary
	 	$	5,000	 
	Annual Bonus
	 	$	5,000	 

     If no election is made, the amount deferred shall be zero.

          (b) Short Plan Year. If a Participant first becomes a Participant
after the first day of a Plan Year, the minimum Base Annual Salary and/or Annual
Bonus deferral shall be an amount equal to the minimum set forth above, multiplied
by a fraction, the numerator of which is the number of complete months remaining in
the Plan Year and the denominator of which is 12.

3

 

          (c) Maximum. For each Plan Year, a Participant may elect to defer a
percentage of his or her Base Annual Salary and/or Annual Bonus otherwise payable in
respect of such Plan Year up to the following maximum amounts:

	 	 	 	 	 
	Deferral	 	Maximum Amount
	Base Annual Salary
	 	 	75	%
	Annual Bonus
	 	 	100	%

     9. Section 3.4 of the Plan is hereby amended in its entirety, effective as of the Closing Date
except as otherwise specified therein, to read as follows:

     3.4 Discretionary Company Matching Contribution. Each Plan Year, the
Company may make a Discretionary Company Matching Contribution on behalf of any or
all Participants depending upon the financial strength of the Company. To the
extent the Company makes a Discretionary Company Matching Contribution for any Plan
Year, the amount of such Discretionary Company Matching Contribution shall be
determined in the sole discretion of the Committee; provided, however, the Company
generally intends to make Discretionary Company Matching Contributions in an amount
equal to fifty percent (50%) of the Participant’s Base Annual Salary deferred and
fifty percent (50%) of the Participant’s Annual Bonus deferred for such Plan Year,
but, in no event shall such Discretionary Company Matching Contributions exceed five
percent (5%) of the Participant’s aggregate Base Annual Salary and Annual Bonus for
the year. To become eligible for the Discretionary Company Matching Contributions,
a Participant must defer a sufficient amount to the United Surgical Partners
International 401(k) Plan (the “401(k) Plan”) to maximize the Company’s matching
contribution under the 401(k) Plan; provided, however, the Discretionary Company
Matching Contribution under the Plan shall be calculated separately from and be in
addition to the Company’s matching contribution under the 401(k) Plan. The
Committee may determine for any Plan Year that no Discretionary Company Matching
Contribution will be made.

     10. Section 3.6 of the Plan shall be amended in its entirety to read as follows:

     3.6 Selection of Deemed Investments.

          (a) The Committee shall select the Deemed Investments whose performance will
measure the amounts to be credited under Section 3.7 to the Account Balances of
Participants. The selection of Deemed Investments shall be for bookkeeping purposes
only, and the Company shall not be obligated to actually invest any money in the
Deemed Investments, or to acquire or maintain any actual investment.

          (b) With respect to any amounts that a Participant elected to defer under the
Plan pursuant to the “deferred stock benefit” feature that was available under the
Plan prior to the Closing Date, such amounts shall be deemed

4

 

invested, as of the Closing Date, in the money market investment fund offered
within the Deemed Investment alternatives. The MSF Blackrock Money Market Portfolio
is the money market investment alternative as of the the date hereof and the
specific Deemed Investment offered in this category is subject to change at the
discretion of the Committee.

     11. Section 3.7 of the Plan shall be amended in its entirety to read as follows:

     3.7 Crediting of Earnings, Gains, Losses, and Changes in Value of Deemed
Investments. The Committee shall determine, in its discretion, the exact times
and methods for crediting or charging each Participant’s Account Balance (and such
Participant’s Elective Deferral Account, Discretionary Company Matching Contribution
Account, and any Annual Deferral Amount paid as an In-Service Distribution under
Section 4.1) with earnings. The Committee may, at any time, change the timing or
methods for crediting earnings to Annual Deferral Amounts, Discretionary Company
Matching Contributions, and payments of benefits and withdrawals under this Plan;
provided, however, that the times and methods for crediting or debiting such items
in effect at any particular time shall be uniform among all Participants and
Beneficiaries.

     12. A new Section 4.3 shall be added to the Plan to read as follows:

     4.3 Cash Out of 2007 Annual Bonus Amount. Pursuant to and in
accordance with Notice 2006-79 promulgated by the Internal Revenue Service to extend
the transition relief applicable to nonqualified deferred compensation plans
otherwise subject to the requirements of section 409A of the Code, the Company may
permit certain Participants, who previously elected to defer any portion of their
Annual Bonus for 2007 pursuant to the “deferred stock benefit” feature that was
available under the Plan prior to the Closing Date, to execute a one-time election
to accelerate payment of all or any portion of the Participant’s Annual Bonus for
2007 that the Participant previously elected to defer and to receive such amounts in
the form of a lump sum cash payment. The Company may impose such other terms and
conditions on any election or payment made pursuant to this Section 4.3 as it
determines, in its sole discretion, to be necessary or advisable in order to comply
with Notice 2006-79. If an eligible Participant does not elect to have such
deferred portion of his or her Annual Bonus for 2007 cashed out or elects to have
less than the entire deferred portion of his or her Annual Bonus for 2007 cashed
out, the amount of such deferral that remains in the Plan will be deemed invested
under the Plan in accordance with Section 3.6(b) hereof.

     13. Section 10.1 of the Plan shall be amended in its entirety to read as follows:

     10.1 Payment of Benefits. All amounts payable pursuant to the Plan
shall be distributed in cash.

     Except as set forth above, the Plan shall continue to read in its current state.

5

 

     IN WITNESS WHEREOF, this First Amendment has been executed by a duly authorized officer of the
Corporation as of the date set forth above.

	 	 	 	 	 	 	 
	 	 	UNITED SURGICAL PARTNERS

INTERNATIONAL, INC.,

a Delaware corporation	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ John J. Wellik	 	 
	 

	 	Title:
	 	 

Senior Vice President
	 	 

6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00125-of-00352.parquet"}]]